Clinical Trial Update: A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describing a single-dose study of CS-1103 to evaluate safety and efficacy in participants with methamphetamine intoxication or m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Intoxication
• Methamphetamine Use Disorder

Drugs mentioned

• CS-1103

Snippet

Sponsor: Clear Scientific, Inc. | Conditions: Methamphetamine Intoxication, Methamphetamine Disorders | Phase 2 | Status: RECRUITING